A vs PRLD · P/E 29, rev $1.88B vs rev $6.5M
Agilent Technologies Inc (A) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
A currently screens at market cap $33.70B and trailing P/E 29.2. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the A and PRLD stock pages for the full models.
Not investment advice.